Ticker Symbol: CCCC
C4 Therapeutics Inc
$41.10 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001662579
Company Profile
C4 Therapeutics is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer and other diseases. This targeted protein degradation approach offers advantages over traditional therapies, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
Website: www.c4thera.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $1.87
Change:
$0.02
(
1.08%)
Days Range: $1.77 - $1.95
Beta: 1.56
52wk. High: $10.42
52wk. Low: $1.51
Ytd. Change -67.56%
50 Day Moving Average: $2.00
200 Day Moving Average: $2.99
Shares Outstanding: 49190855
Valuation
Market Cap: 9.2B
PE Ratio: -0.66
EPS (TTM): -2.85
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A